Also trades as: KNE.V (TSXV) · $vol 0M
KNBIF OTC
Kane Biotech Inc.
1W: +3.2%
1M: -0.2%
3M: -5.3%
YTD: -30.6%
1Y: -43.7%
3Y: -75.4%
5Y: -89.8%
$0.02
-0.00 (-2.79%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-27.6% ▼
Capital Expenditures
$90K
-878.2% ▼
5Y CAGR: -1.5%
Free Cash Flow
-$4M
-30.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-330.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$5M | -$4M | -$5M | $6M |
| Depreciation & Amort. | $78K | $188K | $263K | $239K | $218K |
| Stock-Based Comp. | $465K | $1M | $280K | $442K | $711K |
| Change in Working Capital | -$268K | $1M | -$378K | -$162K | -$6M |
| Other Non-Cash Items | -$407K | -$78K | $433K | $1M | -$5M |
| Operating Cash Flow | -$4M | -$2M | -$3M | -$3M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$126K | -$354K | -$88K | -$9K | -$25K |
| Acquisitions (Net) | $1M | $500K | $500K | $0 | $11M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$1M | -$520K | -$520K | -$107K | -$560K |
| Investing Cash Flow | -$166K | -$374K | -$108K | -$116K | $10M |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | $1M | $2M | -$472K | -$7M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | $2M | -$121K | $3M | -$1M |
| Financing Cash Flow | $4M | $3M | $3M | $3M | -$8M |
| Net Change in Cash | $174K | $145K | -$48K | -$356K | -$2M |
| Cash End of Period | $1M | $1M | $1M | $749K | $359K |
| Free Cash Flow | -$4M | -$3M | -$3M | -$3M | -$4M |